Ledger.Open graph →
SEC Form D · filed April 19, 2016

Confluence Life Sciences, Inc

Offering
$5.4M
Sold
$4.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAINT LOUIS, MO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Charles A. Bolten · St. Louis, MODirectorKyparissia Sirinakis · Baltimore, MDDirectorScott D. Macdonald · Toronto, Ontario, CanadaDirectorDaniel Janiak · St. Louis, MODirectorJennifer Bohnert · St. Louis, MOExecWalter Smith · San Francisco, CAExec · DirectorJoseph Monahan · St. Louis, MOExec · DirectorThomas Smart · St. Louis, MODirectorElizabeth W. Cermak · San Ramon, CADirectorDaniel Janiak · St. Louis, MODirectorJennifer Bohnert · St. Louis, MOExecWalter Smith · St. Louis, MOExec · DirectorJoseph Monahan · St. Louis, MOExec · DirectorThomas Smart · St. Louis, MODirectorKyparissia Sirinakis · Woodstock, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗